Salmedix starts NHL Phase II

Salmedix (San Diego, Calif.) began a Phase II trial of its SDX-105 bendamustine in combination with Rituxan rituximab to treat patients with relapsed, indolent or slowly progressing non-Hodgkin's lymp...